Biogen Inc. buy Guggenheim
Start price
30.04.26
/
50%
€164.34
Target price
30.04.27
€222.82
Performance (%)
8.85%
Price
05.08.26
€178.88
Summary
This prediction is currently active. The BUY prediction by Guggenheim shows slight gains of 8.85%. This prediction currently runs until 30.04.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | -2.187% | -2.187% |
| iShares Core DAX® | 3.153% | 1.504% |
| iShares Nasdaq 100 | 7.431% | -1.584% |
| iShares Nikkei 225® | 8.571% | -4.324% |
| iShares S&P 500 | 4.578% | 1.920% |
Comments by Guggenheim for this prediction
In the thread Biogen Inc. diskutieren
Biogen (BIIB) had its "buy" rating reaffirmed by Guggenheim. They now have a $260.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat